BioCardia, Inc.
BCDA
$1.10
-$0.01-0.90%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 893.00K | 1.24M | 1.13M | 936.00K | 1.37M |
| Gross Profit | -893.00K | -1.24M | -1.13M | -936.00K | -1.37M |
| SG&A Expenses | 730.00K | 1.03M | 885.00K | 552.00K | 683.00K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.62M | 2.27M | 2.01M | 1.49M | 2.05M |
| Operating Income | -1.62M | -2.27M | -2.01M | -1.49M | -2.05M |
| Income Before Tax | -1.61M | -2.26M | -1.98M | -1.48M | -2.05M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.61M | -2.26M | -1.98M | -1.48M | -2.05M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.61M | -2.26M | -1.98M | -1.48M | -2.05M |
| EBIT | -1.62M | -2.27M | -2.01M | -1.49M | -2.05M |
| EBITDA | -1.62M | -2.26M | -2.01M | -1.48M | -2.05M |
| EPS Basic | -0.13 | -0.21 | -0.19 | -0.24 | -0.41 |
| Normalized Basic EPS | -0.08 | -0.13 | -0.12 | -0.15 | -0.25 |
| EPS Diluted | -0.13 | -0.21 | -0.19 | -0.24 | -0.41 |
| Normalized Diluted EPS | -0.08 | -0.13 | -0.12 | -0.15 | -0.25 |
| Average Basic Shares Outstanding | 12.09M | 10.81M | 10.68M | 6.28M | 5.06M |
| Average Diluted Shares Outstanding | 12.09M | 10.81M | 10.68M | 6.28M | 5.06M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |